Overview
Alkaline phosphatase (ALP) is an enzyme found throughout the body, especially in the liver, bones, kidneys, intestines, bile ducts, and, during pregnancy, the placenta. As outlined in the document (pages 2–3), ALP functions optimally at an alkaline pH of 9–10 and exists as different isoenzymes produced by specific tissues. The predominant serum isoenzymes are liver ALP and bone ALP, which play essential roles in bone mineralization, bile secretion, cellular metabolism, and intestinal homeostasis (page 4).
The document highlights Alkaline phosphatase as a biomarker in diagnosing liver diseases, bone disorders, biliary obstruction, metastasis, and several metabolic conditions. Elevated or reduced ALP levels provide valuable clinical clues, but since ALP originates from multiple organs, interpretation often requires correlation with additional tests.
Symptoms
Symptoms prompting Alkaline phosphatase testing relate to disorders of the liver, bile ducts, bones, or metabolic pathways.
Liver and Biliary Symptoms
Based on the indications listed on page 9, ALP is one of the best markers for obstructive jaundice. Symptoms include:
- Yellowing of skin or eyes (jaundice)
- Dark urine / pale stools
- Abdominal pain, especially in the right upper quadrant
- Fatigue and weakness
These symptoms suggest liver damage, cholestasis, or biliary blockage.
Bone-Related Symptoms
Since bone isoenzymes are produced by osteoblasts (page 8), symptoms may include:
- Bone pain or tenderness
- Fractures or bone deformities
- Delayed growth in children
Conditions like rickets, osteomalacia, and Paget’s disease are commonly associated.
Cancer-Related Symptoms
As described in the cancer section (page 6), advanced tumor spread shows markedly elevated Alkaline phosphatase:
- Unexplained weight loss
- Pain due to metastasis
- Fatigue and malaise
Pregnancy-Related Indicators
Page 5 states Alkaline phosphatase may rise to twice normal levels due to placental isoenzymes, often without symptoms, though monitoring may be required.
Causes
The document identifies several pathological and physiological causes behind abnormal Alkaline phosphatase levels.
Causes of High ALP
The chart on page 14 categorizes elevated ALP into levels:
Marked elevation (5× normal):
- Biliary cirrhosis
- Intrahepatic or extrahepatic biliary obstruction
- Paget’s disease
- Hyperparathyroidism
- Osteogenic sarcoma
Moderate elevation (3–5× normal):
- Infectious mononucleosis
- Granulomatous liver infiltration
- Bone metastasis
- Rickets
- Osteomalacia
Mild elevation (up to 3× normal):
- Cirrhosis
- Viral hepatitis
- Pregnancy (placental ALP)
- Physiological increase in growing children
Causes of Low Alkaline phosphatase
As detailed on page 15:
- Malnutrition
- Hypothyroidism (cretinism)
- Celiac sprue
- Milk-alkali syndrome
- Vitamin C deficiency (scurvy)
- Gross anemia
- Pernicious anemia
- Zinc or magnesium deficiency
- Estrogen therapy
- Wilson’s disease
- Hypophosphatemia
Risk Factors
Risk factors are clinical situations where abnormal ALP levels are more likely or where ALP testing is medically indicated.
1. Liver and Bile Duct Disorders
Liver cirrhosis, hepatitis, biliary obstruction, and hepatic metastasis directly influence ALP levels due to high enzyme concentration in liver Kupffer cells (page 8).
2. Bone Disorders and Growth Phases
Individuals with rickets, osteomalacia, Paget’s disease, or children in growth spurts naturally exhibit altered ALP due to active osteoblasts.
3. Pregnancy
Placental ALP levels rise physiologically (page 5).
4. Endocrine and Metabolic Conditions
Hyperparathyroidism, vitamin D deficiency, and mineral deficiencies (zinc/magnesium) affect ALP production and turnover.
5. Cancer and Metastasis
Page 6 explains that ALP rises proportionally with tumor spread, especially when cancers metastasize to the bone or liver.
6. Malabsorption or Nutritional Deficiency
Celiac sprue, malnutrition, and anemia influence ALP synthesis.
Prevention
Prevention involves reducing diagnostic errors, managing modifiable causes, and ensuring accurate ALP measurement.
1. Proper Patient Preparation
A 10–12 hour fasting sample is preferred (page 10) to avoid post-meal variation.
2. Correct Sample Collection
(Page 11)
- Collect 3.0 mL of blood in a red-capped plain tube
- Separate serum promptly
- Refrigerate the sample immediately
- Avoid hemolyzed samples since hemoglobin lowers ALP results (page 16)
3. Avoid Test Interference
(Page 16)
Inhibitors such as oxalates, excess phosphate, bile acids, phenylalanine, and urea may affect enzyme activity.
4. Manage Underlying Deficiencies Early
Correcting zinc, magnesium, vitamin D, and dietary protein deficiencies helps prevent falsely low or abnormal ALP levels.
5. Monitor High-Risk Patients
Those with liver disease, bone disorders, metastasis, or pregnancy benefit from scheduled ALP monitoring to prevent complications.
